On Tuesday, Blueprint Medicines Corp (BPMC) stock saw a decline, ending the day at $90 which represents a decrease of $-2.50 or -2.70% from the prior close of $92.5. The stock opened at $91.63 and ...

Cogent Biosciences' uncertain competitive edge may compel investors to sit on the sidelines. Read more about the cautious ...

On Friday, Blueprint Medicines Corp (BPMC) stock saw a modest uptick, ending the day at $92.55 which represents a slight increase of $3.49 or 3.92% from the prior close of $89.06. The stock opened at ...

Blueprint Medicines' AYVAKIT continues to gain traction among key stakeholders. See more on BPMC stock and the factors ...